|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17.04.25 - 00:33
|
Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025 (Business Wire)
|
|
|
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the first quarter of 2025 after the close of market on Wednesday, May 7, 2025. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day.
The conference call will be webcast live from the company's website and will be available via the following link: https://edge.media-server.com/mmc/p/5r4msrbq. A webcast replay will be available following the conclusion of the live broadcast and will be accessible on the company's website at https://investor.veracyte.com/events-presentations.
The conference call dial-ins can be accessed by registering via this link.
About Veracyte
Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the ...
|
|
|
|
|
|
|
|
|
|
|
20.03.25 - 20:36
|
5 Analysts Assess Veracyte: What You Need To Know (Benzinga)
|
|
|
Latest Ratings for VCYT
DateFirmActionFromTo Mar 2022Stephens & Co.MaintainsOverweight Mar 2022Raymond JamesMaintainsOutperform Mar 2022SVB LeerinkMaintainsOutperform
View More Analyst Ratings for VCYT
View the Latest Analyst Ratings
read more...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
